1. Sample Collection
2.1 From blood of P100 tube (P100_DNA)
2.2 From Blood of EDTA Ttube (EDTA_DNA)
3. DNA Quantity and Quality Assessment
The quantity, quality and integrity of the genomic DNA were assessed by a combination of method that includes picogreen, spectroscopy and electrophoresis.
4. Genotyping Assays and Quality Control
DNA quality assessment and concentration measurement
The yields of P100_DNAs were significantly lower than those of EDTA_DNAs (Tables 1 and 2). The DNA purity represented by its 260/280 ratio value is similar for both P100_DNA and EDTA_DNA sample set (Tables 1 and 2). The quality of the DNA is fairly uniform within each set of sample although some degradation is seen in the EDTA_DNA samples, as indicated by light smear (Figure 2). The EDTA_DNAs that showed more signs of degradation also showed reduced DNA concentration.
Genotyping
The genotyping call rate for both EDTA_DNAs and P100_DNAs were compared. They yielded similar call rates and were both comparable to the internal HapMap control DNA (Table 3).
Figure 1. Buffy coat isolation.
Table 1. DNA sample yield (PicoGreen) and ratio (nanodrop).
DNA Yield | DNA Purity | |||
Samples | P100 | EDTA | P100 | EDTA |
1 | 135 | 340 | 1.79 | 1.9 |
2 | 119 | 344 | 1.85 | 1.89 |
3 | 57 | 129 | 1.88 | 1.88 |
4 | 159 | 640 | 1.86 | 1.88 |
5 | 140 | 430 | 1.86 | 1.88 |
6 | 150 | 673 | 1.86 | 1.9 |
7 | 139 | 425 | 1.74 | 1.88 |
8 | 118 | 240 | 1.87 | 1.86 |
9 | 51 | 86 | 1.87 | 1.83 |
p value | p = 0.00221 | p = 0.09836 |
Table 2. Comparison of yield and purity (two-tailed, Paired Sample t-test).
Genotyping Cell Rate | ||
Samples | P100 | EDTA |
1 | 97.9 | 97.5 |
2 | 97.9 | 97.8 |
4 | 97.4 | 97.5 |
7 | 97.5 | 98.2 |
8 | 97.9 | 98 |
P value | p = 0.67970 |
Table 3. Genotyping call rate (two-tailed, Paired Sample t-test).
Samples | Layers | Yield (μg) | Ratio (260/280) |
P100_06 | Buffy coat | 150 | 1.86 |
RBC | 4.13 | 1.73 | |
P100_07 | Buffy coat | 139 | 1.74 |
RBC | 1.00 | 1.70 | |
P100_08 | Buffy coat | 118 | 1.87 |
RBC | 3.72 | 1.78 | |
P100_09 | Buffy coat | 51 | 1.87 |
RBC | 0.23 | 0.98 |
Appendix. Evaluation of the amount of DNA found in red blood cell (RBC) layer.
Name of the reagent/equipment | Company | Catalogue number |
BD P100 tubes | BD Diagnostics | 366448 |
EDTA tubes | BD Diagnostics | 367863 |
Sucrose | Sigma | S9378 |
Paper clip | Office product | |
15 ml tube | Corning | 430052 |
Red blood cells (RBC) | Qiagen | 158389 (kit) |
Phosphate Buffer Saline (PBS) | Thermo Scientific | SH30256.01 |
BioSprint 96 DNA Blood Kit (48) | Qiagen | 940054 |
1.7 ml microtubes | Axygen | MCT-175-C |
Human Immuno DNA Analysis BeadChip Kit | Illumina | WG-352-1001 |
Bead array reader | Illumina | NA |
GenomeStudio Software | Illumina | N/A |
Laboratory tests can be done on the cellular or fluid portions of the blood. The use of different blood collection tubes determines the portion of the blood that can be analyzed (whole blood, plasma or serum). Laboratories involved in studying the genetic basis of human disorders rely on anticoagulated whole blood collected in EDTA-containing vacutainer as the source of DNA for genetic / genomic analysis. Because most clinical laboratories perform biochemical, serologic and viral testing as a first step in phenotypic outcome investigation, anticoagulated blood is also collected in heparin-containing tube (plasma tube). Therefore when DNA and plasma are needed for simultaneous and parallel analyses of both genomic and proteomic data, it is customary to collect blood in both EDTA and heparin tubes. If blood could be collected in a single tube and serve as a source for both plasma and DNA, that method would be considered an advancement to existing methods. The use of the compacted blood after plasma extraction represents an alternative source for genomic DNA, thus minimizing the amount of blood samples processed and reducing the number of samples required from each patient. This would ultimately save time and resources.
The BD P100 blood collection system for plasma protein preservation were created as an improved method over previous plasma or serum collection tubes1, to stabilize the protein content of blood, enabling better protein biomarker discovery and proteomics experimentation from human blood. The BD P100 tubes contain 15.8 ml of spray-dried K2EDTA and a lyophilized proprietary broad spectrum cocktail of protease inhibitors to prevent coagulation and stabilize the plasma proteins. They also include a mechanical separator, which provides a physical barrier between plasma and cell pellets after centrifugation. Few methods have been devised to extract DNA from clotted blood samples collected in old plasma tubes2-4. Challenges from these methods were mainly associated with the type of separator inside the tubes (gel separator) and included difficulty in recovering the clotted blood, the inconvenience of fragmenting or dispersing the clot, and obstruction of the clot extraction by the separation gel.
We present the first method that extracts and purifies genomic DNA from blood drawn in the new BD P100 tubes. We compare the quality of the DNA sample from P100 tubes to that from EDTA tubes. Our approach is simple and efficient. It involves four major steps as follows: 1) the use of a plasma BD P100 (BD Diagnostics, Sparks, MD, USA) tube with mechanical separator for blood collection, 2) the removal of the mechanical separator using a combination of sucrose and a sterile paperclip metallic hook, 3) the separation of the buffy coat layer containing the white cells and 4) the isolation of the genomic DNA from the buffy coat using a regular commercial DNA extraction kit or a similar standard protocol.
Laboratory tests can be done on the cellular or fluid portions of the blood. The use of different blood collection tubes determines the portion of the blood that can be analyzed (whole blood, plasma or serum). Laboratories involved in studying the genetic basis of human disorders rely on anticoagulated whole blood collected in EDTA-containing vacutainer as the source of DNA for genetic / genomic analysis. Because most clinical laboratories perform biochemical, serologic and viral testing as a first step in phenotypic outcome investigation, anticoagulated blood is also collected in heparin-containing tube (plasma tube). Therefore when DNA and plasma are needed for simultaneous and parallel analyses of both genomic and proteomic data, it is customary to collect blood in both EDTA and heparin tubes. If blood could be collected in a single tube and serve as a source for both plasma and DNA, that method would be considered an advancement to existing methods. The use of the compacted blood after plasma extraction represents an alternative source for genomic DNA, thus minimizing the amount of blood samples processed and reducing the number of samples required from each patient. This would ultimately save time and resources.
The BD P100 blood collection system for plasma protein preservation were created as an improved method over previous plasma or serum collection tubes1, to stabilize the protein content of blood, enabling better protein biomarker discovery and proteomics experimentation from human blood. The BD P100 tubes contain 15.8 ml of spray-dried K2EDTA and a lyophilized proprietary broad spectrum cocktail of protease inhibitors to prevent coagulation and stabilize the plasma proteins. They also include a mechanical separator, which provides a physical barrier between plasma and cell pellets after centrifugation. Few methods have been devised to extract DNA from clotted blood samples collected in old plasma tubes2-4. Challenges from these methods were mainly associated with the type of separator inside the tubes (gel separator) and included difficulty in recovering the clotted blood, the inconvenience of fragmenting or dispersing the clot, and obstruction of the clot extraction by the separation gel.
We present the first method that extracts and purifies genomic DNA from blood drawn in the new BD P100 tubes. We compare the quality of the DNA sample from P100 tubes to that from EDTA tubes. Our approach is simple and efficient. It involves four major steps as follows: 1) the use of a plasma BD P100 (BD Diagnostics, Sparks, MD, USA) tube with mechanical separator for blood collection, 2) the removal of the mechanical separator using a combination of sucrose and a sterile paperclip metallic hook, 3) the separation of the buffy coat layer containing the white cells and 4) the isolation of the genomic DNA from the buffy coat using a regular commercial DNA extraction kit or a similar standard protocol.
Laboratory tests can be done on the cellular or fluid portions of the blood. The use of different blood collection tubes determines the portion of the blood that can be analyzed (whole blood, plasma or serum). Laboratories involved in studying the genetic basis of human disorders rely on anticoagulated whole blood collected in EDTA-containing vacutainer as the source of DNA for genetic / genomic analysis. Because most clinical laboratories perform biochemical, serologic and viral testing as a first step in phenotypic outcome investigation, anticoagulated blood is also collected in heparin-containing tube (plasma tube). Therefore when DNA and plasma are needed for simultaneous and parallel analyses of both genomic and proteomic data, it is customary to collect blood in both EDTA and heparin tubes. If blood could be collected in a single tube and serve as a source for both plasma and DNA, that method would be considered an advancement to existing methods. The use of the compacted blood after plasma extraction represents an alternative source for genomic DNA, thus minimizing the amount of blood samples processed and reducing the number of samples required from each patient. This would ultimately save time and resources.
The BD P100 blood collection system for plasma protein preservation were created as an improved method over previous plasma or serum collection tubes1, to stabilize the protein content of blood, enabling better protein biomarker discovery and proteomics experimentation from human blood. The BD P100 tubes contain 15.8 ml of spray-dried K2EDTA and a lyophilized proprietary broad spectrum cocktail of protease inhibitors to prevent coagulation and stabilize the plasma proteins. They also include a mechanical separator, which provides a physical barrier between plasma and cell pellets after centrifugation. Few methods have been devised to extract DNA from clotted blood samples collected in old plasma tubes2-4. Challenges from these methods were mainly associated with the type of separator inside the tubes (gel separator) and included difficulty in recovering the clotted blood, the inconvenience of fragmenting or dispersing the clot, and obstruction of the clot extraction by the separation gel.
We present the first method that extracts and purifies genomic DNA from blood drawn in the new BD P100 tubes. We compare the quality of the DNA sample from P100 tubes to that from EDTA tubes. Our approach is simple and efficient. It involves four major steps as follows: 1) the use of a plasma BD P100 (BD Diagnostics, Sparks, MD, USA) tube with mechanical separator for blood collection, 2) the removal of the mechanical separator using a combination of sucrose and a sterile paperclip metallic hook, 3) the separation of the buffy coat layer containing the white cells and 4) the isolation of the genomic DNA from the buffy coat using a regular commercial DNA extraction kit or a similar standard protocol.